• Provide strategic leadership and medical expertise for the clinical development of our cutting-edge antibody portfolio in IBD. • Design, plan, and oversee the execution of clinical studies, with a focus on proof-of-concept and later-stage development. • Partner with teams across Biostatistics, Regulatory Affairs, Development Operations, Translational Science, and other key functions to ensure cohesive and efficient program execution. • Contribute medical and scientific content for regulatory documents including INDs, Investigator Brochures, Clinical Study Reports, and regulatory submissions and responses. • Ensure participant safety through proactive safety monitoring, data review, and clinical judgment in response to emerging data. • Serve as a primary medical representative for assigned programs, interfacing with investigators, academic experts, and key opinion leaders (KOLs). • Provide medical leadership within clinical teams and mentor as the organization grows. • Support strategic portfolio decisions and organizational initiatives as needed.